Department of Neurology, Mayo Clinic, Rochester, MN, USA.
Department of Neurology, Center of Expertise for Parkinson & Movement Disorders, Donders Institute for Brain, Radboud University Medical Center, Cognition and Behaviour, Nijmegen, The Netherlands.
J Parkinsons Dis. 2024;14(7):1353-1368. doi: 10.3233/JPD-240036.
Levodopa is the most widely used medication for the symptomatic treatment of Parkinson's disease and, despite being an "old" drug, is still considered the gold standard for offering symptomatic relief. The pharmacokinetic and pharmacodynamics of levodopa have been studied extensively. Our review explores the molecular mechanisms that affect the absorption of this drug, focusing on the large intra- and interindividual variability of absorption that is commonly encountered in daily clinical practice, and on the interaction with other medications. In addition, we will explore the clinical implications of levodopa absorption variability and address current and future strategies for researchers and clinicians.
左旋多巴是治疗帕金森病症状的最广泛应用的药物,尽管它是一种“老”药,但仍然被认为是提供症状缓解的金标准。左旋多巴的药代动力学和药效学已经得到了广泛的研究。我们的综述探讨了影响这种药物吸收的分子机制,重点关注了在日常临床实践中经常遇到的吸收的大的个体内和个体间变异性,以及与其他药物的相互作用。此外,我们还将探讨左旋多巴吸收变异性的临床意义,并为研究人员和临床医生探讨当前和未来的策略。